January 15, 2004 Regular News Bar sections adopt legislative positions Bar sections adopt legislative positions The Real Property Probate and Trust Law Section has added nine legislative positions to its lobbying agenda, while the Family Law and Entertainment, Arts and Sports Law sections have added one each.The positions were reviewed and authorized by the Bar Board of Governors at its December meeting.Under Bar rules, sections are given wide latitude on lobbying issues, but the board reviews the positions to ensure they meet broad guidelines and don’t conflict with Bar-wide legislative activities.RPPTL positions authorized include:• Amending F.S. §733.212 to include deadlines for filing a claim to exempt property and for filing an election for an elective share.• Repealing F.S. §734.1025 because the dollar amount for summary administrations has been increased in F.S. §§735.201-2068, making the first law duplicative. The section also said the second set of laws has better procedures for notifying creditors.• Amending several statutes and creating a new one to allow a court-appointed guardian to contest a ward’s revocable trust or trust amendment if the court has found that appears to be in the ward’s best interest. The section said that would protect incapacitated persons from loss or harm from an ongoing trust which is invalid due to fraud, duress, mistakes, or other problems.• Amending F.S. §201.02 to clarify when the documentary stamp tax applies in real estate transactions.• Clarifying F.S. §689.07 that when a deed is given to a trustee who is also part of a trust that the deed does not convey the title to the trustee personally. The change is needed to correct a recent contrary interpretation by a bankruptcy court.• Fixing glitches in F.S. §558, which sets out an alternative dispute resolution method of fixing construction defects. The section said the law, while well-intentioned, is difficult to comply with and has vague provisions.• Supporting legislation that gives condominium associations more governing flexibility, including on leasing restrictions, but also ensures that buyers are informed of restrictions and other covenants.• Transferring F.S. §§689.02 and 689.265 to F.S. Ch. 720 to eliminate confusion on whether those sections apply to properties other than residential parcels in communities as defined in Ch. 720.• Opposing proposed F.S. §518.117, which would alter the fundamental duties of loyalty and full and fair disclosure of trustees solely for the pecuniary benefit of corporate fiduciaries.The Family Law Section was authorized to seek amendments to F.S. Chs. 61 and 742 to clarify that judges can retroactively modify temporary support orders, even without a showing of a substantial change in circumstances.The board also ratified a resolution from the Entertainment, Arts and Sports Law Section supporting full funding of arts and arts education programs in Florida.
Dec 7, 2004 (CIDRAP News) – The federal government is buying 1.2 million doses of flu vaccine made in Germany to augment the strained US supply, the Department of Health and Human Services (HHS) announced today.HHS Secretary Tommy Thompson announced the purchase of the vaccine, made by GlaxoSmithKline, at a news teleconference. “We’ll have it available this month,” he said. “This will allow us to get more vaccine into the hands of those who need it most.”Because the vaccine is not licensed in the United States and licensing is a lengthy process, it will be used under “investigational new drug” (IND) rules, Thompson said. That means people will have to sign a consent form acknowledging their awareness of possible risks before getting a shot. But Thompson and Lester Crawford, acting commissioner of the Food and Drug Administration (FDA), said the vaccine is safe.The vaccine, called Fluarix, is used in 30 countries. The FDA reviewed GlaxoSmithKline’s manufacturing processes and inspected the plant that makes the vaccine before HHS decided to buy it, Thompson said.The consent form will explain “what the public should expect in terms of risk,” said Crawford. “What the public should know at this point is that the vaccine is not investigational because we have real questions about it, but because the company elected not to enter the US market last year, so they didn’t apply for approval.” He called the probability of safety problems with the vaccine “very low indeed.”Thompson said GlaxoSmithKline has agreed to supply up to 4 million doses to the US under IND rules, but he didn’t predict how many doses HHS might buy beyond the initial 1.2 million.The 1.2 million doses will increase the total US supply for this season to slightly more than 62 million doses, which includes about 58 million doses from Aventis Pasteur and 3 million doses of MedImmune’s FluMist, Thompson said.Thompson said the Centers for Disease Control and Prevention will distribute the GlaxoSmithKline vaccine doses where they are needed and will release a distribution plan in a few days. The company is charging HHS about $7 per dose, but there will be some additional costs for distribution, he said.GlaxoSmithKline said the IND rules provide that the vaccine can be given to people at least 3 years old who qualify for vaccination under the current US guidelines, which reserve the shots for people in high-risk groups.Another foreign firm viewed as a potential supplier of flu vaccine to the United States, Canada’s ID Biomedical, announced today that it must save its remaining doses for Canada, according to a Canadian Press (CP) report. HHS officials had previously said they were considering buying 1.2 million doses from the Vancouver, B.C., company.The company said it was selling the doses on the Canadian market at the request of the government, according to the CP report. The story said reports of the US vaccine shortage spurred an unusual Canadian demand for flu shots earlier this fall, sparking fears of a shortage in Canada.At the news conference, Crawford acknowledged the ID Biomedical announcement but said the FDA was still discussing the possibility of buying some vaccine from the company. The CP report said FDA officials spent a week inspecting the firm’s vaccine plant in Ste.-Foy, Que.Crawford also said that two companies have announced this week that they want to enter the US flu vaccine market, one as early as 2005 and the other by 2007. This year Aventis Pasteur and MedImmune are the only companies providing licensed flu vaccines in the US. California-based Chiron Corp. was to have supplied up to 48 million doses before contamination problems at the company’s plant in Liverpool, England, prompted British authorities to shut down the plant, triggering the American vaccine shortage.Crawford didn’t name the two companies planning to enter the market, but ID Biomedical yesterday announced a long-term agreement to sell flu vaccine to three US wholesalers, starting as early as next year, depending on licensing of the vaccine. The company said the agreement covers at least 8 years. The firm’s production capacity in 2005 will be about 22 million doses, officials said.GlaxoSmithKline, in a news release about the sale of doses to HHS, said it has “a long-term strategy” to seek FDA licensing of Fluarix.In other comments, Crawford said the FDA has been reviewing proposals by Illinois, New Mexico, and New York City to buy a total of 750,000 doses of non-US-licensed flu vaccine made abroad by Aventis. “By the end of the week we expect to have gotten through all of the information,” but he didn’t predict whether the FDA will approve the plans.
Advertisement Mikel Arteta and Granit Xhaka are forging a good relationship (Picture: Getty Images)Mikel Arteta has revealed the details of the heart-to-heart he had with Granit Xhaka which convinced the Swiss midfielder to stay at the club.Xhaka has had a turbulent season with the Gunners and his career in north London looked to be over after a public fallout with the fans which saw him stripped of the captaincy.A deal to take 27-year-old to Hertha Berlin looked to be agreed, but Arteta arrived to take over as manager in December and he quickly put a stop to those plans.The Spaniard has described how he spoke to the former Arsenal captain and explained that he sees him as a big part of his team going forward, as well as setting out a plan to heal the wounds of the previous few months.AdvertisementAdvertisementADVERTISEMENT‘The first message for him was that I wanted to understand how he was feeling, why he was feeling that way,’ said Arteta.‘I wanted him to hear from me my opinion on him, and that I was ready to support him and that I was ready to push the club to be supportive of him too, because I thought he could be a really, really good player for us and he could enjoy playing under me in this football club.‘I tried to convince him that way. He thought about it, he had a very positive response afterwards, and I think he changed his mind.’ Comment Advertisement Metro Sport ReporterThursday 9 Jan 2020 11:37 pmShare this article via facebookShare this article via twitterShare this article via messengerShare this with Share this article via emailShare this article via flipboardCopy link986Shares Xhaka’s low point came as he was booed off against Crystal Palace (Picture: Rex Features)The level-headed new Arsenal manager was keen to downplay the problems Xhaka had gone through earlier this season, describing them as commonplace in the modern game.The Swiss has started three of Arteta’s four games in charge of Arsenal so far and the Spaniard just wants to put the issues in the past.‘It’s very common now,’ said Arteta. ‘Every club has its own issues. Some things come within the club, some within the media, some from social media.More: FootballRio Ferdinand urges Ole Gunnar Solskjaer to drop Manchester United starChelsea defender Fikayo Tomori reveals why he made U-turn over transfer deadline day moveMikel Arteta rates Thomas Partey’s chances of making his Arsenal debut vs Man City‘It’s very difficult nowadays to have one full year where everything is perfect. It’s the environment, we have to deal with that and hopefully in a few months nobody remembers those issues.‘Of course it’s not ideal when players respond and it creates an instability. So as much as we can avoid it, the better.’Arsenal are looking to make it three wins on the spin under their new boss when they travel to take on Crystal Palace in the Premier League on Saturday.MORE: Mikel Arteta against Gabriel Martinelli leaving Arsenal to join Brazil’s Olympic qualification tournamentMORE: Mikel Arteta explains plans for Emile Smith-Rowe as Arsenal work on loans for three youngsters Mikel Arteta explains how he convinced Granit Xhaka to stay at Arsenal
Glo premier league Leaders SC Medeama were demolished 4-0 by Tema Youth at the Tema Stadium on Sunday. Champions Asante Kotoko shared the spoils against Liberty at the Baba Yara Stadium. Hearts needed a penalty to beat King Faisal on the return of the Ghana Premier League on Sunday.FT: Kotoko 3-3 Liberty ProfessionalsFT: Hearts 1-0 King FaisalFT: TeMa Youth 4-0 MedeamaFT: Ebusua Dwarfs 2-0 Aduana StarsFT: Berekum Chelsea 0-0 Ashantigold FT: All Stars 1-0 Heart of LionsFT: New Edubiase 1-0 Berekum Arsenals (Saturday)FT: Real Tamale United 1-3 Amidaus Professionals (Saturday)